Why I Trusted This Protocol - My 2020 Cancer History

When I was diagnosed with esophageal adenocarcinoma in September 2025, I was not starting from zero. I had been here before.

The 2020 Diagnosis

In 2020 I was diagnosed with endometrial cancer. The tumor had penetrated more than 50% through the uterine wall. It had not metastasized beyond the uterus.

I chose surgery. I had a total hysterectomy including removal of the ovaries. That part of conventional treatment made sense to me and I did it without hesitation.

What I declined was brachytherapy. My oncologist recommended it. I understood the recommendation. I declined anyway — not out of fear or denial, but because I had been researching an alternative approach and I believed it was worth trying.

Joe Tippens and the Protocol That Changed My Thinking

Around that time I had learned about Joe Tippens, a man who documented his experience using fenbendazole — a veterinary anthelmintic — as part of a self-designed cancer protocol after a terminal lung cancer diagnosis. His story circulated widely in integrative oncology communities and sparked serious research interest in fenbendazole’s anticancer mechanisms.

I built my own protocol based on what I had learned from his approach and from my own research as a Doctor of Acupuncture and Oriental Medicine. It included fenbendazole delivered with pharmaceutical-grade DMSO as a carrier — DMSO dramatically improves fenbendazole’s bioavailability by facilitating transdermal and gastrointestinal absorption. It included pawpaw extract for mitochondrial complex I inhibition. It included bitter apricot seeds — three per day — for their amygdalin content and caspase-mediated apoptosis activity. And it included a comprehensive vitamin protocol.

I continued this protocol for approximately a year, then transitioned to maintaining the vitamin regime without the other components.

Six Years Later

I have been cancer free from the endometrial cancer for six years.

I want to be precise about what I can and cannot claim here. I had surgery. The surgery removed the tumor. I cannot separate the contribution of surgery from the contribution of the integrative protocol. What I can say is that I declined the additional conventional treatment my oncologist recommended, I used this protocol, and I have had no recurrence in six years.

That outcome — whatever caused it — is why when I received the esophageal adenocarcinoma diagnosis in 2025, I knew exactly where to turn. I returned to fenbendazole with DMSO, pawpaw, and bitter apricot seeds. I added turkey tail PSK, medicinal mushrooms, photobiomodulation, bu zhong yi qi tang, colostrum, and liver support. The 2025 protocol is more comprehensive and more targeted than the 2020 protocol — informed by five more years of research and a much deeper understanding of cancer stem cell biology.

Barrett’s Esophagus — A Separate Story

I want to be clear that my esophageal adenocarcinoma is completely unrelated to the 2020 endometrial cancer. These are two entirely separate diseases.

I had been diagnosed with Barrett’s esophagus — a precancerous condition involving abnormal cell changes in the esophageal lining — years earlier, but honestly had not been actively monitoring it. I managed symptoms with antacids and didn’t have strong warning signs. In 2025 I decided it had been long enough and went to get it checked. That decision led directly to the esophageal adenocarcinoma diagnosis. Barrett’s is a known precursor to esophageal adenocarcinoma — my cancer developed from that condition, not from any spread or recurrence of the uterine cancer.

In retrospect I wish I had monitored it more closely. I share that honestly because it may be useful to someone reading this.

Why This Matters

I share this history because it directly explains the confidence behind my current protocol. This is not a first experiment. These are not compounds I discovered after a frightening new diagnosis and grabbed at desperately. Fenbendazole, DMSO, pawpaw, and apricot seeds are tools I have used before, researched carefully, and — to the best of my knowledge and with all appropriate caveats about confounding variables — used successfully.

That prior experience does not prove the protocol works. It does mean I had rational, evidence-informed reasons to trust it enough to use it again. And it means I am not a newcomer to this territory.

As always — this is my story and my research. Your decisions belong to you and your physicians.